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234 Status of fat soluble vitamins in Scandinavian CF patients
K. Nilsson1, H.V. Olesen2, I.E. Moen4, T. Pressler3, G. Fluge5, L. Hjelte1,
for the Scandinavian CF Study Consortium. 1Karolinska University Hospital
Huddinge, Stockholm, Sweden; 2Aarhus University Hospital, Aarhus, Denmark;
3Rigshospitalet, Copenhagen, Denmark; 4Ullevaal University Hospital, Oslo,
Norway; 5Haukeland University Hospital, Bergen, Norway
Aims: To investigate the intake of vitamin A, E, D in 898 Scandinavian CF patients
(median age 18.3 (0.3−66) y) and relate the intake to serum concentration and the
fatty acid pattern of serum phospholipids (s-PLs).
Methods: Vitamin (vit) intake was calculated from self-reported food records and
vit supplements. S-retinol, s-a tocopherol, s-25-hydroxy vit D and s-PLs were
analysed. Sub analyses were made from 407 CF patients completing a 7d precoded
food record.
Results: Around 90% of the patients reported supplementation with vit A, E and D.
There were no differences between the countries, no gender but an age difference.
Median vit A intake from supplements were 1714 (DK), 857(N) and 1350(S)mg (p
total <0.001; all p< 0.001), for vit E 144, 126 and 209mg (p total <0.001; DK vs
N= ns). More Danish revealed low levels of vit A (<0.7mmol/l) than Norwegian
and Swedish patients (p< 0.01). More Danish and Norwegian patients revealed low
levels (<11.6mmol/l) of vit E than did Swedish ones (p< 0.01). For PI patients
low levels of vit A were seen in 3.2 of children and 5.7% of adults, and of vit E
in 10.1 and 18% respectively, with center differences. More PI adults than children
revealed low levels of vit E and D (p< 0.01 and p< 0.001). There was a correlation
between s-levels of vit E and mole% LA, AA and DHA.
Conclusions: Adherence to vitamin therapy was higher than previously described.
Patients at centres that do not monitor s-vitamin levels regularly revealed lower
levels of the vit studied. Adult CF patients are more at risk of having decreased
s-vitamin levels than children.
Supported by: An unrestricted grant by Solvay Pharma (DK, S, N).
235 Serum vitamin E and IL-6 are inﬂuenced by type of physical
training in patients with CF
M. Sahlberg1, B. Andersson2, B. Strandvik1. 1Institute of Clinical Sciences,
Go¨teborg, Sweden; 2Institute of Clinical Immunology, Go¨teborg, Sweden
Background: Vitamin E has been found to inﬂuence muscle strength. Patients with
cystic ﬁbrosis (CF) have generally low vitamin E and an increased lipid peroxida-
tion. IL-6 increases during muscle performance, the mechanism is unknown.
The aim of this study was to evaluate if vitamin E and cytokine levels in serum
were inﬂuenced by training in patients with CF.
Methods: Twenty patients (8 females) 16−35 years of age, with mean (SD) FEV1
91 (20.6) % of predicted, participated in a three month study with either strength
or endurance training three times/week. All patients had unchanged vitamin E sup-
plementation during the study period. Blood samples were collected and analysed
for vitamin E and cytokines.
Results: Mean (SD) serum vitamin E levels were at baseline 21 (6.4)mg/mL (ref.
13.5−36.8). No signiﬁcant change was seen after three months but patients with
endurance training increased signiﬁcantly but not those performing strength training
(p = 0.02). TNFa and IL-1b were not increased at start or later. Mean (SD) IL6 was
signiﬁcantly increased at baseline and after three months 79 (59) and 78 (39) pg/mL,
respectively, compared to controls, being 41 (19) pg/mL, p< 0.0001), but only
4−6 patients had increased values compared to upper ref. range. Strength training
increased IL-6, but by endurance training there was a trend that IL6 decreased.
Conclusion: There seemed to be an inverse relation between vitamin E and IL-6
in patients with CF during regular training, which might indicate an increased lipid
peroxidation in patients performing strength training as vitamin E decreased and
IL6 increased. This trend was not seen in endurance training.
Supported by: Erica Lederhausen Foundation.
236 Serum zinc concentrations of the CF population above the age
of 4 years: a cross-sectional evaluation
S. Van Biervliet, J.P. Van Biervliet, D. Declercq, M. Genetello, E. Robberecht.
Paediatric Gastroenterology, Ghent University, Ghent, Belgium
Aim: Assess the risk of zinc (Zn) deﬁciency in the older cystic ﬁbrosis (CF)
population.
Method: Cross sectional investigation of all CF patients above the age of 4 followed
at the Ghent university centre between 2002 and 2003. Data on age, weight and
height z-score, pancreatic and pulmonary functions, chronic pseudomonas infection
and CF transmembrane conductance regulator (CFTR) mutations were collected.
Serum Zn, vitamin A, E, retinol binding protein (RBP), albumin, sedimentation
rate, total IgG and cholesterol were determined. Serum Zn was compared with a
local healthy control group (1) and with literature data (3).
Results: 101 patients (median age 16 years) were included. There was no difference
in serum Zn concentration between CF patients and controls. In CF patients no
difference in serum Zn concentration between pancreatic sufﬁcient or insufﬁcient
patients was seen. Serum Zn was not associated to nutritional status or height
Z-score. A signiﬁcant association serum Zn to serum albumin (p< 0.0005) and to
vitamin A (p< 0.01) was seen. No associations of serum Zn to serum vitamin E,
RBP, cholesterol or CFTR were present. There is a signiﬁcant association serum
Zn – forced vital capacity (p< 0.01). Serum Zn was not associated to inﬂammatory
parameters or chronic pseudomonas infection.
Conclusion: Comparison of CF patients with local controls revealed no signiﬁcant
differences. However, since persisting steatorrhoea increases Zn loss (2) and 12.6%
of our population has a serum Zn below the P 2.5 value of the NHANES II study
(3), there could remain an increased risk of Zn deﬁciency in some CF patients.
Further on the association with pulmonary function needs more investigation.
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Cystic ﬁbrosis (CF) is a disease that leads to serious disturbances in nutritional
status and bone calciﬁcation.
Aim of the study: comparisson of two methods for assessment of bone mineraliza-
tion: DEXA and hand radiograms in diagnosing bone density disturbances of any
kind, osteopenia or osteoporosis that is.
Material and Methods: the study was performed in a group of 26 CF patients (10F,
16M), aged 7−30 yrs. Nutritional status was assessed using BMI, Cole’s Index and
BMC. Radiograms of non-dominant hand were assessed according to normalized
optical density comparing to aluminum standard. Total Body and Spine bone density
were assessed using DEXA method on DPX-L system. For statistical analysis,
backward stepwise binary logistic regression (Wald’s test) was used.
Results: In the regression analysis aquired data allowed to ﬁnd that using BMC,
Cole’s index and hand radiograms markers (BT, CBDN2CT, NCBDN, CT_BT100,
CBDN) we can diagnose bone mass disturbances in 86.7% of studied patients.
False negative results were obtained in 2 patients and false positive were also in
2 patients.
Conclusions: Aquired results allow to acertain that hand radiograms method can
possibly be an alternative for DEXA in screening of bone density disturbances in
CF patients, but studies on a bigger group of patients is needed.
The study was supported by grant of Ministry of Science and Higher Education
no 2 P05E 041 28.
